Clinical Trial Update: Molecular Signatures of Cutaneous Dupilumab Response [Phase 4]

View source ↗

Summary

Clinical trial update describing a Phase 4 study investigating molecular signatures of dupilumab response in atopic dermatitis, sponsored by the University of C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: University of California, San Francisco | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING